Arizona State Retirement System’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $592K | Buy |
8,477
+1,816
| +27% | +$133K | ﹤0.01% | 1455 |
|
|
2026
Q1 | $479K | Buy |
+6,661
| New | +$379K | ﹤0.01% | 1482 |
|
|
2023
Q2 | – | Sell |
-3,631
| Closed | -$38.3K | – | 2215 |
|
|
2023
Q1 | $38.3K | Buy |
3,631
+106
| +3% | +$3.21K | ﹤0.01% | 2201 |
|
|
2022
Q4 | $120K | Buy |
3,525
+150
| +4% | +$7.26K | ﹤0.01% | 2072 |
|
|
2022
Q3 | $162K | Buy |
3,375
+41
| +1% | +$2.44K | ﹤0.01% | 1967 |
|
|
2022
Q2 | $190K | Buy |
3,334
+8
| +0.2% | +$505 | ﹤0.01% | 1954 |
|
|
2022
Q1 | $269K | Buy |
3,326
+28
| +0.8% | +$4.14K | ﹤0.01% | 1863 |
|
|
2021
Q4 | $668K | Sell |
3,298
-13
| -0.4% | -$2.82K | 0.01% | 1362 |
|
|
2021
Q3 | $892K | Buy |
3,311
+60
| +2% | +$14.4K | 0.01% | 1159 |
|
|
2021
Q2 | $837K | Sell |
3,251
-231
| -7% | -$63.9K | 0.01% | 1230 |
|
|
2021
Q1 | $1.04M | Buy |
3,482
+23
| +0.7% | +$7.16K | 0.01% | 1072 |
|
|
2020
Q4 | $882K | Sell |
3,459
-121
| -3% | -$31.3K | 0.01% | 1121 |
|
|
2020
Q3 | $891K | Buy |
3,580
+933
| +35% | +$293K | 0.01% | 976 |
|
|
2020
Q2 | $920K | Sell |
2,647
-106
| -4% | -$33.1K | 0.01% | 794 |
|
|
2020
Q1 | $737K | Sell |
2,753
-3,898
| -59% | -$1.21M | 0.01% | 801 |
|
|
2019
Q4 | $2.15M | Buy |
6,651
+4,469
| +205% | +$1.3M | 0.03% | 721 |
|
|
2019
Q3 | $596K | Sell |
2,182
-28
| -1% | -$10.3K | 0.01% | 1410 |
|
|
2019
Q2 | $1.18M | Sell |
2,210
-2,894
| -57% | -$1.45M | 0.01% | 1260 |
|
|
2019
Q1 | $2.57M | Buy |
5,104
+19
| +0.4% | +$11.3K | 0.03% | 823 |
|
|
2018
Q4 | $2.51M | Sell |
5,085
-2,317
| -31% | -$1.4M | 0.03% | 748 |
|
|
2018
Q3 | $6.77M | Buy |
7,402
+1,280
| +21% | +$1.09M | 0.06% | 379 |
|
|
2018
Q2 | $4.48M | Buy |
6,122
+3,462
| +130% | +$3.99M | 0.05% | 512 |
|
|
2018
Q1 | $4.24M | Sell |
2,660
-14,985
| -85% | -$19.3M | 0.04% | 561 |
|
|
2017
Q4 | $15.8M | Buy |
17,645
+12,235
| +226% | +$7.24M | 0.15% | 126 |
|
|
2017
Q3 | $1.95M | Buy |
5,410
+14
| +0.3% | +$4.38K | 0.02% | 727 |
|
|
2017
Q2 | $1.58M | Buy |
5,396
+53
| +1% | +$15.3K | 0.02% | 702 |
|
|
2017
Q1 | $1.88M | Buy |
5,343
+100
| +2% | +$22.5K | 0.03% | 607 |
|
|
2016
Q4 | $965K | Buy |
5,243
+527
| +11% | +$107K | 0.01% | 949 |
|
|
2016
Q3 | $1.22M | Hold |
4,716
| – | – | 0.02% | 770 |
|
|
2016
Q2 | $1.01M | Buy |
4,716
+73
| +2% | +$16.3K | 0.01% | 850 |
|
|
2016
Q1 | $958K | Buy |
4,643
+213
| +5% | +$40.9K | 0.01% | 907 |
|
|
2015
Q4 | $1.12M | Buy |
4,430
+194
| +5% | +$39.9K | 0.01% | 832 |
|
|
2015
Q3 | $696K | Buy |
+4,236
| New | +$749K | 0.01% | 1023 |
|
Other funds holding NKTR
TSC
BI
VPC
Arizona State Retirement System's NKTR Position: Q2 2026 in Review
Arizona State Retirement System increased its Nektar Therapeutics (NKTR) stake by 27% in Q2 2026, buying an estimated $133K and bringing the position to 8,477 shares worth $592K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.
Arizona State Retirement System first reported a position in NKTR in Q3 2015 and has held it in 33 quarters since. The position peaked at $15.8M in Q4 2017. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.
- Arizona State Retirement System held 8,477 shares of Nektar Therapeutics worth $592K as of Q2 2026.
- Arizona State Retirement System bought 1,816 Nektar Therapeutics shares in Q2 2026, an estimated $133K.
- Nektar Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1455 holding.
- Arizona State Retirement System first reported a position in Nektar Therapeutics in Q3 2015 and has held it in 33 quarters since.
- Arizona State Retirement System's Nektar Therapeutics position peaked at $15.8M in Q4 2017.
- 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.
Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.